LMO3 reprograms visceral adipocyte metabolism during obesity.

Saved in:
Bibliographic Details
Title: LMO3 reprograms visceral adipocyte metabolism during obesity.
Authors: Wagner G; Department of Laboratory Medicine, Medical University of Vienna, 1090, Vienna, Austria., Fenzl A; Clinical Division of Endocrinology and Metabolism, Department of Medicine III, Medical University of Vienna, 1090, Vienna, Austria., Lindroos-Christensen J; Department of Laboratory Medicine, Medical University of Vienna, 1090, Vienna, Austria.; Novo Nordisk, Maaloev, Denmark., Einwallner E; Department of Laboratory Medicine, Medical University of Vienna, 1090, Vienna, Austria., Husa J; Department of Laboratory Medicine, Medical University of Vienna, 1090, Vienna, Austria., Witzeneder N; Department of Laboratory Medicine, Medical University of Vienna, 1090, Vienna, Austria., Rauscher S; Core Facilities, Medical University of Vienna, 1090, Vienna, Austria., Gröger M; Core Facilities, Medical University of Vienna, 1090, Vienna, Austria., Derdak S; Core Facilities, Medical University of Vienna, 1090, Vienna, Austria., Mohr T; Institute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center, Medical University of Vienna, 1090, Vienna, Austria., Sutterlüty H; Institute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center, Medical University of Vienna, 1090, Vienna, Austria., Klinglmüller F; Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, 1090, Vienna, Austria.; Austrian Medicines & Medical Devices Agency, 1200, Vienna, Austria., Wolkerstorfer S; Department of Laboratory Medicine, Medical University of Vienna, 1090, Vienna, Austria.; University of Applied Sciences, FH Campus Wien, 1100, Vienna, Austria.; Institute of Cardiovascular Prevention, Ludwig-Maximilians-University, 80336, Munich, Germany., Fondi M; University of Applied Sciences, FH Campus Wien, 1100, Vienna, Austria., Hoermann G; Department of Laboratory Medicine, Medical University of Vienna, 1090, Vienna, Austria.; Central Institute of Medical and Chemical Laboratory Diagnostics, University Hospital Innsbruck, 6020, Innsbruck, Austria., Cao L; Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, 43210, USA., Wagner O; Department of Laboratory Medicine, Medical University of Vienna, 1090, Vienna, Austria., Kiefer FW; Clinical Division of Endocrinology and Metabolism, Department of Medicine III, Medical University of Vienna, 1090, Vienna, Austria., Esterbauer H; Department of Laboratory Medicine, Medical University of Vienna, 1090, Vienna, Austria., Bilban M; Department of Laboratory Medicine, Medical University of Vienna, 1090, Vienna, Austria. martin.bilban@meduniwien.ac.at.; Core Facilities, Medical University of Vienna, 1090, Vienna, Austria. martin.bilban@meduniwien.ac.at.
Source: Journal of molecular medicine (Berlin, Germany) [J Mol Med (Berl)] 2021 Aug; Vol. 99 (8), pp. 1151-1171. Date of Electronic Publication: 2021 May 20.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Springer International Country of Publication: Germany NLM ID: 9504370 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1440 (Electronic) Linking ISSN: 09462716 NLM ISO Abbreviation: J Mol Med (Berl) Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first